Patients are taking a more active role in their journey to therapy, and direct-to-patient (DTP) models are transforming how pharmaceutical manufacturers engage and support them. Recent federal initiatives have encouraged manufacturers to adopt DTP approaches, aiming to provide greater pricing transparency, broader access, and more seamless patient support. However, these models also introduce new complexities.
In this session, our team will:
- Explore the history of pharma DTP models and where they’re headed.
- Examine consumer-driven behaviors that enable patient education and support.
- Discuss the rise of cash-pay options alongside traditional fulfillment.
- Evaluate if a DTP model is right for your brand — and how to scale it.
- And much more.
Register now to walk away with actionable strategies to assess, launch, and optimize a direct-to-patient model that effectively meets patient needs in today’s competitive, evolving healthcare landscape.